Dynavax Technologies | Capitalização De Mercado



Market Capitalization Alterar Data
AbbVie USD 347.61B 23.02B 2025-05
Adma Biologics USD 4.06B 667M 2024-12
Amgen USD 150.06B 10.09B 2025-05
AstraZeneca GBP 166.72B 7.79B 2025-05
Biogen USD 17.89B 4.39B 2025-05
BioMarin Pharmaceutical USD 11.72B 824M 2025-05
Bristol-Myers Squibb USD 101.45B 22.65B 2025-05
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 129.47B 10.21B 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Merck USD 212.34B 13.54B 2025-05
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 137.09B 6.62B 2025-05
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
TG Therapeutics USD 4.69B 1.07B 2024-12
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Dynavax Technologies Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.